ArticleMolecular cancer therapeutics2024

ASCL1 Restrains ERK1/2 to Promote Survival of a Subset of Neuroendocrine Lung Cancers.

Ana Martin-Vega et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.